AI assistant
Sending…
Mawson Infrastructure Group Inc. — Director's Dealing 2017
Nov 27, 2017
35202_dirs_2017-11-27_0af5ae15-4956-42d2-bf88-7997cf7c916b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Wize Pharma, Inc. (WIZP)
CIK: 0001218683
Period of Report: 2017-11-16
Reporting Person: Eisenberg Or (Acting CEO, CFO, Treas & Secy.)
More from Mawson Infrastructure Group Inc.
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Apr 6
Major Shareholding Notification
2026
Mar 18
Major Shareholding Notification
2026
Feb 10
Major Shareholding Notification
2026
Feb 10
Regulatory Filings
2026
Feb 6
Proxy Solicitation & Information Statement
2026
Feb 4
Regulatory Filings
2026
Feb 2
Major Shareholding Notification
2026
Jan 30